2025-521000-22-00招募中1 期
A clinical trial to learn about the effects of DAK539 on the blood levels of repaglinide, midazolam, drospirenone, and ethinyl estradiol in people with advanced cancer
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 24
- 试验地点
- 9
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（18-64 Years, 65+ Years）
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
Novartis Pharma Arzneimittel GmbH
Scientific
Novartis Pharma AG
研究点 (9)
Loading locations...
相似试验
已完成
1 期
A clinical trial to learn how an investigational drug (norucholic acid) is absorbed, distributed, broken down, and removed from the body when given to people with kidney problemsNonalcoholic fatty liver disease (NAFLD)Primary sclerosing cholangitis (PSC)2023-505862-27-00Dr. Falk Pharma GmbH, Dr. Falk Pharma GmbH48
招募中
1 期
A clinical trial to learn how an investigational drug (vimseltinib) is absorbed, distributed, broken down, and removed from the body when given to people with liver problemsTenosynovial Giant Cell Tumor (TGCT)Malignant Solid Tumors (MST)2023-503415-15-00Deciphera Pharmaceuticals Inc.32
招募中
不适用
A Phase I/II exploratory clinical trial to evaluate the efficacy and safety of RBBM-S1 in patients requiring lumbar interbody fusion for degenerative lumbar disease, in comparison with the standard treatment of autologous bone grafting.lumbar stenosis, spondylolisthesis, spondylolysis, scoliosis, instability, disc diseasejRCT203125056936
招募中
1 期
A Phase I study to evaluate the safety and efficacy of L19IL2 in combination with ruxolitinib in patients with advanced solid tumors.Advanced solid tumors, specifically:
• metastatic clear cell renal carcinoma
• proficient mismatch repair / microsatellite stable (pMMR/MSS), BRAF-V600E-mutant negative colorectal carcinoma
• locally advanced or metastatic pancreatic adenocarcinoma2025-522243-17-00Philogen S.p.A.96
招募中
1 期
A trial to investigate the safety and pharmacokinetics of GRT6019 in healthy male participants.Not applicable for phase I study2025-523587-20-00Gruenenthal GmbH24